Veeva Systems Inc. Reports Strong First Quarter Results for Fiscal 2026

Veeva reported total revenues of $759.0 million, marking a 17% year-over-year increase from $650.3 million in the same quarter last year. Subscription services revenues also saw significant growth, reaching $634.8 million, up 19% from $534.0 million year-over-year. This strong performance underscores Veeva's successful execution of its short and long-term strategies.

The company’s operating income rose to $233.7 million, a remarkable 51% increase from $155.2 million in the prior year. Non-GAAP operating income for the quarter was reported at $349.9 million, up 34% from $260.9 million in the same period last year.

Net income for the quarter was $228.2 million, a 41% increase compared to $161.7 million in the previous year. Non-GAAP net income also grew to $327.8 million, up 33% from $247.0 million year-over-year. This translated to a fully diluted net income per share of $1.37, compared to $0.98 for the same period last year. The non-GAAP fully diluted net income per share was $1.97, up from $1.50 year over year.

CEO Peter Gassner expressed pride in the company’s performance, stating, "I consider this our best first quarter ever. We executed with speed, quality, and innovation across all areas on short-term objectives and long-term initiatives aligned to our values and 2030 goals." The CEO credited the Veeva team and customers for their partnership and success.

CFO Brian Van Wagener added, "Delivering results ahead of guidance for all metrics again demonstrates our focused execution and sizable market opportunity." He emphasized that Veeva has crossed its 2025 revenue run rate goal of $3 billion, setting a solid foundation for future growth.

One of the most significant initiatives is Veeva AI, which aims to embed artificial intelligence capabilities across Veeva applications and the Veeva Vault Platform. Scheduled for its first release in December 2025, Veeva AI will enhance productivity and automation within the life sciences industry through application-specific AI Agents and user-defined AI Shortcuts.

At the recent Commercial Summit held in May, Veeva showcased its latest innovations and the upcoming AI capabilities. The summit highlighted the success of over 80 Vault CRM customers, with ambitious plans to grow that number to 200 by next year, including collaborations with three top 20 biopharmaceutical companies.

Veeva has also expanded its commercial data offerings with Veeva CRM Pulse, further enhancing its suite of connected data products, which now includes reference, deep, performance, and pulse data on a unified data architecture. This expansion supports Veeva's vision of delivering exceptional data and software solutions that foster operational efficiency and customer-centricity.

Looking ahead, Veeva has provided guidance for its fiscal second quarter ending July 31, 2025, projecting total revenues between $766 million and $769 million. The company anticipates a non-GAAP operating income in the range of $335 million to $337 million, and non-GAAP fully diluted net income per share between $1.89 and $1.90.

Additionally, for its fiscal year ending January 31, 2026, Veeva expects total revenues to be between $3,090 million and $3,100 million, with a non-GAAP operating income of around $1,360 million and non-GAAP fully diluted net income per share of approximately $7.63.

Veeva Systems Inc. has demonstrated remarkable growth and innovation in its first quarter of fiscal 2026, setting a strong foundation for the future. With its commitment to integrating AI and expanding its service offerings, Veeva is well-positioned to continue its trajectory of success in the life sciences industry. The upcoming conference call promises further insights into the company's strategies and future directions, as stakeholders eagerly await the next steps in Veeva's impressive journey.